AITRICS Selected as the 14th “Innovation Icon” by Korea Credit Guarantee Fund
2025-11-10
Strengthening Financial Foundation with Up to KRW 20 Billion in Credit Support Over Three Years
![[%EA%B8%B0%EC%97%85%EB%A1%9C%EA%B3%A0]%20%EC%97%90%EC%9D%B4%EC%95%84%EC%9D%B4%ED%8A%B8%EB%A6%AD%EC%8A%A4(AITRICS)_917a8.jpg](/upload/smartupload/[%EA%B8%B0%EC%97%85%EB%A1%9C%EA%B3%A0]%20%EC%97%90%EC%9D%B4%EC%95%84%EC%9D%B4%ED%8A%B8%EB%A6%AD%EC%8A%A4(AITRICS)_917a8.jpg)
AITRICS (CEO Kwang Joon Kim), a company specializing in artificial intelligence(AI) technology announced on the 10th that it has been selected as one of the 14th batch of “Innovation Icon” companies by the Korea Credit Guarantee Fund (KODIT), a flagship scale-up program.
The “Innovation Icon” program supports startups with new technologies or innovative business models to grow into global unicorns. AITRICS was chosen as one of the five final companies following a rigorous selection process, including document review, on-site evaluation, and assessments by a panel of expert judges.
Through this selection, AITRICS will receive ▲Credit guarantees of up to KRW 20 billion over three years ▲The lowest guarantee fee rate (0.5%) ▲Additional guarantee fee support through partner banks ▲Services to support sustainable growth, including overseas expansion, consulting, and promotional assistance
AITRICS was recognized for its ability to deliver practical, clinically applicable medical AI, its established clinical evidence through collaborations with major domestic medical institutions, and its expanding global partnerships. These factors demonstrated both the company’s technological capabilities and growth potential.
This selection enables AITRICS to secure financial stability to execute its mid- to long-term growth strategies. The support will serve as a growth engine for advancing technology and expanding business domestically and internationally in a more stable manner.
Cheol-jin Choi, Chief Financial Officer of AITRICS, said, “Being selected as an Innovation Icon is an official acknowledgment of AITRICS’ technological growth and sustainability. Leveraging the secured financial and non-financial support, we will accelerate the development of technologies that deliver real value in clinical settings and expand collaborations with global partners.”

